SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-18-001310
Filing Date
2018-04-13
Accepted
2018-04-13 16:37:57
Documents
1
Period of Report
2018-04-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form305735001_04122018.html 3  
1 OWNERSHIP DOCUMENT form305735001_04122018.xml 3 7648
  Complete submission text file 0000921895-18-001310.txt   10382
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 800 THIRD AVENUE 31ST FLOOR NEW YORK NY 10022
Business Address
COUCHMAN JONATHAN (Reporting) CIK: 0001265094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36435 | Film No.: 18754741

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020 212.729.4962
Xstelos Corp. (Reporting) CIK: 0001571659 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-36435 | Film No.: 18754739

Mailing Address 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020 (212) 729-4962
Couchman Family Fund (Reporting) CIK: 0001737322 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36435 | Film No.: 18754740